24 May 2022
Navigating the digital pathway in the NHS with DigitalHealth.London
Our acceptance into DigitalHealth.London’s Accelerator programme, gave us the opportunity to significantly increase our credibility and visibility with NHS stakeholders. At the same time, we also grew our understanding of UK Information Governance (IG) and cyber security requirements.
24 May 2022
Chelsea and Westminster hospitals launch clinical trial to remotely monitor stroke risk
As part of their CW Innovation programme, the Chelsea and Westminster Hospital NHS Foundation Trust and its charity CW+ started a clinical trial exploring the use of FibriCheck to detect atrial fibrillation (AF) in people who recently suffered a stroke.
7 June 2021
World Heart Rhythm Week: listening to your heart saves lives
Atrial fibrillation (AF) is the most common heart rhythm disorder. People as young as 40 have a 1 in 4 chance of developing AF in their lifetime, making them 5 times more likely to suffer a stroke. In an effort…
22 March 2021
Daiichi Sankyo and FibriCheck announce digital partnership set to transform at-home AF detection and diagnosis
Atrial Fibrillation (AF) is one of the leading causes of stroke and often goes undiagnosed due to lack of symptoms.1 It is estimated that 300,000 people are living with undiagnosed AF and that over 2,000 lives could be saved every…
30 November 2020
Dutch clinic prescribes remote monitoring to 777 heart patients during the COVID-19 pandemic
FibriCheck enables large scale teleconsultations at Maastricht University Medical Centre+
8 June 2020
First step towards the Asia-Pacific region
FibriCheck gains approval from Australia’s Therapeutic Goods Administration (TGA) FibriCheck, the mobile app capable of detecting heart rhythm disorders, was granted an Australian Register of Therapeutic Goods Certificate by the Australian Government Department of Health last week. As the first…
3 June 2020
FibriCheck guards you while you sleep
Night monitoring now closer than ever after successful beta test If you’re familiar with atrial fibrillation, you’ll know it can be a dangerous condition – the heart rhythm disorder is responsible for around 25% of all strokes1. You’ll also know…
22 April 2020
Guaranteeing continuity of care during the lockdown and beyond
TeleCheck-AF remote screening project goes live across Europe It’s no secret the COVID-19 pandemic is placing enormous pressure on our healthcare system. Capacity in our hospitals and clinics is stretched thin. And some patients may find it hard to get…
30 March 2020
FibriCheck’s new medical smartwatch app gives smartwatch manufacturers a competitive edge
A world first - FibriCheck app automatically detects both silent and intermittent atrial fibrillation at night, dramatically reducing the risk of stroke in 40-plussers Hasselt, Belgium, 31 March 2020 - FibriCheck, the first CE- and FDA-approved medical app, today announces…
FibriCheck selected to join the NHS Innovation Accelerator
FibriCheck has been announced as one of 11 innovations selected to join the award-winning NHS Innovation Accelerator (NIA) in 2020 FibriCheck is thrilled to be among the new innovations joining the 2020 NIA programme. FibriCheck is an innovative, hardware-free…